Arrhythmogenesis toxicity of aconitine is related to intracellular ca(2+) signals

Yu-hong Zhou1, Xian-mei Piao, Xue Liu

  • 1Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), Harbin Medical University, Harbin, Heilongjiang 150081, PR China.

Insights

Aconitine toxin increases intracellular calcium by enhancing L-type calcium currents and altering NCX and SERCA2a expression in rat heart cells. This leads to triggered activities and delayed after-depolarizations, explaining its arrhythmogenic toxicity.

Area of Science:

  • Cardiology
  • Molecular Pharmacology
  • Cell Physiology

Background:

  • Aconitine is a known toxin that causes cardiac arrhythmias by affecting sodium channels.
  • The impact of aconitine on intracellular calcium signaling in cardiomyocytes was previously uncharacterized.

Purpose of the Study:

  • To investigate the effects of aconitine on intracellular calcium signals in rat ventricular myocytes.
  • To elucidate the mechanism underlying aconitine-induced arrhythmogenic toxicity.

Main Methods:

  • Whole-cell patch-clamp techniques were used to record action potentials and triggered activities.
  • L-type calcium currents (ICa-L), caffeine-induced calcium release, and the expression of NCX and SERCA2a were measured.
  • Verapamil was used to assess the role of calcium channels in aconitine's effects.

Main Results:

  • Aconitine prolonged action potential duration and induced triggered activities and delayed after-depolarizations at higher concentrations.
  • Aconitine significantly increased ICa-L density and altered its activation and inactivation kinetics.
  • Aconitine increased calcium release induced by caffeine and altered the expression of NCX and SERCA2a.

Conclusions:

  • Aconitine elevates intracellular calcium by accelerating ICa-L and modulating NCX and SERCA2a expression.
  • The increased intracellular calcium triggers arrhythmias, including delayed after-depolarizations.
  • Aconitine's arrhythmogenic toxicity is closely linked to its disruption of intracellular calcium homeostasis.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...